Navigation Links
American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics'
Date:2/25/2009

um/podium.cfm?Pevent=011)

  • Rare Long-Term Study Shows No New Knee Disability Even Long After Surgery

Patients who were older than 40 and as old as 60 when they underwent ACL surgery reported long-term "excellent function" and "high activity" levels as many as 20 years after the reconstructive surgery. Most reported being able to perform normal activities and reported an ability to lead as normal a lifestyle as those who had never undergone knee surgery.

Wheelchair Users and Rotator Cuff Injuries

(http://www3.aaos.org/education/anmeet/anmt2009/podium/podium.cfm?Pevent=383)

  • 50 percent Report Disabling Pain, Women at Higher Risk

Unlike the able-bodied population, where age is the major risk factor for "shoulder girdle" problems such as rotator cuff tears in the shoulder and bursitis, paraplegic patients show additional risk factors for shoulder injuries. The duration of paraplegia and the amount of athletic activity are strong indicators for future shoulder injuries among the paralyzed. Wheelchair dependence significantly affects the possibility of shoulder damage diagnosis, as well as the sex of the paraplegic patient. Paraplegic women were found to be at much higher risk of painful shoulder problems than paraplegic men.

Stress Fractures as Indicators of Underlying Bone Health

('/>"/>

SOURCE American Academy of Orthopaedic Surgeons
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Atritech to Participate in Late-Breaking Clinical Trial Presentation at American College of Cardiology Meeting
2. American Heart Association EMS Survey Uncovers Deficiencies in Response, Treatment and Transfer of Patients With Most Deadly Heart Attacks
3. Advances in Science and Treatment of Pain Presented at 25th Annual American Academy of Pain Medicine Meeting January 28 - 31, 2009
4. American Dairy Provides Business Update
5. Quality Colonoscopy Exam Remains Best Strategy for Detection of Polyps and Cancers According to Experts From the American College of Gastroenterology
6. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
7. Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL
8. Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology
9. Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting
10. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
11. GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ewswire-FirstCall/--Vermillion,Inc.(VRML)(PinkShee...zationandDisclosureStatementtoday,November24,2009,...Delaware.AhearingtoconsiderapprovaloftheDisclosure...hthehearingontheconfirmationofthePlanscheduledforJ...allclaimsinfull.ThePlanisexpected,ifapproved,toall...
(Date:11/24/2009)...wire/--Inadditiontofamily,friendsandhealth,cancers...rThanksgivinggratitudelist. ,, "Theyheardthefac...dofMonday,sverdictstotaling$103millionindamagesaga...000womennationwidewhohavesuedWyethandPfizerpharmac...Prempro.Wisneskiandtheothervictimsofhormonetherapy...
(Date:11/24/2009)...ewswire/--ZargisMedicalCorp.,asubsidiaryofSpeedusC...eResearch(NYSE: SI ),todayannouncedthatitsZargisCa...deofCBS, TheEarlyShow duringasegmentinwhichMarkJan...vewinningproductsfromthepublication,s2009"BestofWh...edtelevisionmorningnewstalkshowbroadcastbyCBSfromN...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Maryland Woman Thankful for Wyeth Verdicts 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 31 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 11 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 21 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 31 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 4Cell Therapeutics Inc 28CTI 29 to Report Third Quarter Financial Results on November 5 60483 1Lupus Research Institute 3A Benlysta 28TM 29 Trial Results in an Historic Research Breakthrough and Victory for People With Lupus 14678 1Lupus Research Institute 3A Benlysta 28TM 29 Trial Results in an Historic Research Breakthrough and Victory for People With Lupus 14678 2
... EnVivo Pharmaceuticals, Inc.,a privately held bio...egenerative diseases, today announced progress on ...chizophrenia and Huntington,s,diseases. EnVivo Ph...orally,active Alpha 7 Nicotinic Acetylcholine Rece...ts associated with Alzheimer,s disease and,Schizop...
...h Joint Venture Between Bristol-Myers Squibb, Co...n HIV Treatment -, PRINCETON, N.J. and FOSTER CIT...ol-Myers Squibb Company (NYSE: BMY ) and Gilead S...t Health Canada has approved ATRIPLA(R),(efavirenz...fumarate 300,mg) for the treatment of HIV-1 infect...
Other Medicine Technology:EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimer's, Schizophrenia and Huntington's Diseases 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 4Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 5Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 6Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 7Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 8Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 9
(Date:11/25/2009)...f a statistically significant survival benefit fro... receptor (ER)-positive tumors had high levels of ...ha S118-P), according to a brief communication pub...ational Cancer Institute . , Approximately 50% o...eclinical studies have shown that ER-alpha S118-P ...
(Date:11/25/2009)...short to draw definite conclusions, experts say, ...-- In diabetic patients with blocked coronary arte...s at one year whether patients undergo bypass surg...ers report. , Bypass surgery has been the stand...artery disease. However, less invasive approaches ...
(Date:11/25/2009)...others to overlook needed care, study finds , ...other,s depression can worsen her child,s asthma, ...study of 262 black mothers and their children foun...symptoms had more frequent asthma symptoms, while ... had less frequent asthma symptoms. , The Johns...
(Date:11/25/2009)...- MISSIONSkincare ®isproudtosupportGNC,seffor...annualSt.Jude ThanksandGiving campaign,$1fromthepu...(TM)LipBalm willbedonatedtoSt.Jude.Additionally,GN...ionatcheckoutatoneoftheir5,000+retaillocationsorat...duringtheir2009 ThanksandGiving campaign. ,, "W...
(Date:11/25/2009)...ine carried into the body on a carefully engineere...sfully eliminate tumors in mammals, scientists rep...l Medicine . , The new approach, pioneered by bi..., uses plastic disks impregnated with tumor-specif...ram the mammalian immune system to attack tumors. ...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
... education come fewer chronic problems, study find...eople who are wealthy and educated appear to have ...ife. , Researchers from the British Economic &...cated were less likely to have depression, high-bl...
..., May 18 Combining two chemotherapy drugs with tr...static HER2+ breast cancer may offer physicians an...he 45th Annual Meeting of the American Society o...stuzumab offers a treatment option that is at leas...
...18 A medication that helps stop the growth of new...some patients with aggressive thyroid cancer, rese...nnual meeting of the American Society of Clinica...th the drug pazopanib either stopped growing, or q...
... officials say the disease is no more dangerous th...ay News) -- While most cases of swine flu continue...from the new H1N1 virus is slightly higher than th... than seasonal influenza, but not necessarily subs...
...8 Dr. Andree Bates, President of the Pharmaceutic... MasterClass on how to tell if you are making the ...s, WHAT: MasterClass on the latest techniques... 12 June 2009, WHERE: 1 Northumberland Avenue,...
...frican-American women who were younger at menarche...re likely to report a history of childhood sexual ...r at Boston University,s Slone Epidemiology Center... The study, which appears currently on-line in th...
Other Medicine News:Health News:Money May Matter, Health-Wise, in Old Age 2Health News:Mayo Clinic Researchers Say Triple Drug Combination is Promising Option to Treat Metastatic HER2+ Breast Cancer 2Health News:Mayo Clinic Researchers Say Triple Drug Combination is Promising Option to Treat Metastatic HER2+ Breast Cancer 3Health News:Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer, Mayo Clinic Researchers Report 2Health News:Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer, Mayo Clinic Researchers Report 3Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 2Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 3Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 4Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 5Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 6Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 7Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 8Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 9Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 10Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 11Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 12Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 13Health News:MEDIA ALERT - Eularis to Hold Pharmaceutical Marketing ROI MasterClass in London 2Health News:Study finds higher prevalence of early menarche among survivors of childhood sexual abuse 2
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: